Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome December 17, 2024
Five years of National Biopharma Mission: Has it made healthcare affordable in India? December 17, 2024
Lytix Biopharma – Lytix launches Retail Offering via Primary Bid and Nordnet, in parallel with private placement December 17, 2024
Lytix Biopharma AS: Private placement and retail offer via PrimaryBid successfully completed December 16, 2024
Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024 November 28, 2024